Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10,470 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
PRMT-1 and p120-Catenin as EMT Mediators in Osimertinib Resistance in NSCLC.
Racherla KS, Dovalovsky K, Patel M, Harper E, Barnard J, Nasifuzzaman SM, Smith M, Sikand R, Drinka E, Puri N. Racherla KS, et al. Among authors: patel m. Cancers (Basel). 2023 Jul 1;15(13):3461. doi: 10.3390/cancers15133461. Cancers (Basel). 2023. PMID: 37444572 Free PMC article.
Treatment of Metastatic Melanoma with a Combination of Immunotherapies and Molecularly Targeted Therapies.
Rager T, Eckburg A, Patel M, Qiu R, Gantiwala S, Dovalovsky K, Fan K, Lam K, Roesler C, Rastogi A, Gautam S, Dube N, Morgan B, Nasifuzzaman SM, Ramaswami D, Gnanasekar V, Smith J, Merchant A, Puri N. Rager T, et al. Among authors: patel m. Cancers (Basel). 2022 Aug 3;14(15):3779. doi: 10.3390/cancers14153779. Cancers (Basel). 2022. PMID: 35954441 Free PMC article. Review.
Resistance to Molecularly Targeted Therapies in Melanoma.
Patel M, Eckburg A, Gantiwala S, Hart Z, Dein J, Lam K, Puri N. Patel M, et al. Cancers (Basel). 2021 Mar 5;13(5):1115. doi: 10.3390/cancers13051115. Cancers (Basel). 2021. PMID: 33807778 Free PMC article. Review.
Potential Telomere-Related Pharmacological Targets.
Berei J, Eckburg A, Miliavski E, Anderson AD, Miller RJ, Dein J, Giuffre AM, Tang D, Deb S, Racherla KS, Patel M, Vela MS, Puri N. Berei J, et al. Among authors: patel m. Curr Top Med Chem. 2020;20(6):458-484. doi: 10.2174/1568026620666200109114339. Curr Top Med Chem. 2020. PMID: 31916516 Review.
Rhabdomyolysis Secondary to Clenbuterol Use and Exercise.
Grimmer NM, Gimbar RP, Bursua A, Patel M. Grimmer NM, et al. Among authors: patel m. J Emerg Med. 2016 Feb;50(2):e71-4. doi: 10.1016/j.jemermed.2015.09.006. Epub 2015 Oct 9. J Emerg Med. 2016. PMID: 26482831
A Phase 1 dose escalation and expansion trial of the next-generation oral SERD camizestrant in women with ER-positive, HER2-negative advanced breast cancer: SERENA-1 monotherapy results.
Hamilton E, Oliveira M, Turner N, García-Corbacho J, Hernando C, Ciruelos EM, Kabos P, Borrego MR, Armstrong A, Patel MR, Vaklavas C, Twelves C, Boni V, Incorvati J, Brier T, Gibbons L, Klinowska T, Lindemann JPO, Morrow CJ, Sykes A, Baird R. Hamilton E, et al. Among authors: patel mr. Ann Oncol. 2024 May 8:S0923-7534(24)00138-8. doi: 10.1016/j.annonc.2024.04.012. Online ahead of print. Ann Oncol. 2024. PMID: 38729567
10,470 results
You have reached the last available page of results. Please see the User Guide for more information.